Clinical trials begin for anti-obesity device

01/17/2013 | Boston Herald

An anti-obesity device that forms a physical barrier between food and part of the intestine has achieved reductions in blood sugar levels and weight loss, according to the developer, GI Dynamics. The company has started clinical trials of the EndoBarrier, which is targeted at obese patients with type 2 diabetes.

View Full Article in:

Boston Herald

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR